Active-ingredient Dossier
Mesalazine
Active-ingredient Dossier for Mesalazine (aminosalicylate). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: Mesalazine
- Brand: MESALZ
- Brand: MESASAL
- Brand: PENTASA
- Brand: SALOFALK
- Brand: MEZAVANT
- Therapeutic area: Gastroenterology
What is Mesalazine Mesalazine is an aminosalicylate .
Australian brands containing
Mesalazine — ASACOL — Mesalazine — MESALZ — MESASAL — PENTASA — SALOFALK — MESALAZINE — APO-MESALAZINE MR — MEZAVANT — COHANA — MESALAZINE ZYDUS — ZYDASA
Therapeutic areas
Mesalazine is registered in gastroenterology (12 brands) and immunology (3 brands) .
Sponsor landscape
Mesalazine is marketed by nine sponsors: KSJ Pharmatech, Southern Cross Pharma, Takeda Pharmaceuticals, Sun Pharma, Chiesi, and Viatris .
PBS and regulatory activity
Six mesalazine brands have PBS-listed items, with the latest PBS schedule date of 1 May 2026 . In the 2018–19 financial year, mesalazine recorded government expenditure of $75,476,107 across 340,547 scripts . The latest PBAC outcome for mesalazine was recorded on 1 November 2020 .